Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
about
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.New therapies and vaccines for bacterial meningitis.Update on the safety of linezolid.Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studiesNew therapeutic agents for resistant Gram-positive infections.Staphylococcal skin infections in children: rational drug therapy recommendations.Use of linezolid in children: an overview of recent advances.Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.Pharmacological issues of linezolid: an updated critical review.Nocardiosis in transplant recipients.Linezolid: a promising option in the treatment of Gram-positives.Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.Tooth discoloration after treatment with linezolid.Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.The Oxazolidinones.
P2860
Q30251593-EFD90D72-7CDA-4A9D-B7E0-51C7E77F226EQ33380788-4BDF6022-F6C9-4DA6-85C6-450E482D9764Q34768547-FC7821CA-A4E8-4E40-BD26-3F7B4B05852EQ34987632-1564BF4C-9848-48F5-A359-6FB74197AB13Q35013856-240F7314-6227-4C30-A8B4-792ADC8072ECQ35917308-5D47A8E0-255A-4CB1-9ABF-A63D271A9371Q36116435-71E61574-2F9B-40AD-AB03-E609BD335D65Q36688930-01D5B15A-40A0-473F-854C-E30437874EC6Q37322249-3C8CBA40-BD23-4235-A1B5-3E105B9F30C0Q37763074-5FAAE3D8-E5FE-4DAC-A5CA-89786220A466Q38165815-B8F5A417-36A2-4A2B-B694-9C06C17C3682Q39044932-B6EEF525-A2BC-4203-819C-9E6D3E6DA5C4Q42687502-1E08E186-057B-40E0-BD34-38299F06DFFFQ44437069-908A319C-17D9-4623-8EAF-E0CCFF8D715AQ51505589-13D6646F-42CF-4182-83A8-EFB2617A536DQ51726843-C2C8FCD7-FAAE-444C-A8D4-DF6AF1338113
P2860
Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@en
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@nl
type
label
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@en
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@nl
prefLabel
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@en
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@nl
P2093
P1476
Linezolid for the treatment of ...... diatric Pneumonia Study Group.
@en
P2093
D C Anderson
F G Lobeck
J L Blumer
J S Bradley
K M Edwards
L Patterson
Linezolid Pediatric Pheumonia Study Group. Pharmacia and Upjohn
S L Kaplan
P304
P356
10.1097/00006454-200105000-00004
P577
2001-05-01T00:00:00Z